Trauma-focused Psychotherapy for PTSD and HIV
(TFPP-PLWH Trial)
Trial Summary
What is the purpose of this trial?
People living with HIV (PLWH) have a higher rate of post-traumatic stress disorder (PTSD) diagnosis than the general population. Comorbid PTSD is also associated with negative HIV-related health outcomes. Unfortunately, little outcome research has examined the usefulness of PTSD treatments for PTSD. This pilot study adapts for PLWH a non-exposure based psychotherapy for PTSD focused on reflecting on one's emotions and relationships and understanding and working through how trauma may have disrupted them. The study team is interested in better understanding the needs of PLWH with PTSD, learning whether PLWH with PTSD find this treatment acceptable and helpful, and beginning to understand the relationship between HIV-related health factors (e.g., inflammation and stress biology) and PTSD, and how these health factors may improve during treatment.
Will I have to stop taking my current medications?
The trial requires that you stay on your current psychiatric or psychotropic medications if they have been stable for at least 2 months.
What data supports the effectiveness of the treatment Trauma-focused psychodynamic psychotherapy (TFPP) for PTSD and HIV?
Research shows that Trauma-focused psychodynamic psychotherapy (TFPP) has been used effectively for PTSD in various populations, including veterans and LGBTQ individuals, by addressing emotional and psychological impacts of trauma. While specific studies on TFPP for PTSD and HIV are not available, its success in treating PTSD in other groups suggests potential benefits.12345
Is trauma-focused psychodynamic psychotherapy (TFPP) safe for humans?
How is Trauma-focused Psychodynamic Psychotherapy (TFPP) different from other treatments for PTSD?
Trauma-focused Psychodynamic Psychotherapy (TFPP) is unique because it is a brief, manualized therapy that focuses on attachment and emotions, and it explicitly considers identity-related and societal factors, which can be particularly beneficial for individuals facing minority stress, such as LGBTQ patients.12579
Research Team
Barbara Milrod, MD
Principal Investigator
Montefiore Medical Center
Eligibility Criteria
This trial is for people living with HIV who also have PTSD. Participants must have a confirmed diagnosis of PTSD with a certain severity score and be on stable psychiatric medication for at least two months, which will continue during the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive trauma-focused psychodynamic psychotherapy twice-weekly for 24 sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Trauma-focused psychodynamic psychotherapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montefiore Medical Center
Lead Sponsor
American Psychoanalytic Association
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator